The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
D3 is different in that D3 takes T4 and makes something called reverse T3 reverse T3 is very similar to T3 except for a very important difference which is it doesn't activate the receptor that T3 activates so it occupies the receptor without activating it so in effect you can think of reverse T3 as anti-t3
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.